PRAVAFENIX

This brand name is authorized in Austria, Croatia, Cyprus, Estonia, France, Ireland, Italy, Lithuania, Netherlands, Poland, Spain.

Active ingredients

The drug PRAVAFENIX contains a combination of these active pharmaceutical ingredients (APIs):

1	Pravastatin UNII 3M8608UQ61 - PRAVASTATIN SODIUM
	Pravastatin is a competitive inhibitor of 3-hydroxy–3-methylglutaryl-coenzyme A (HMG-CoA) reductase, the enzyme catalyzing the early rate limiting step in cholesterol biosynthesis, and produces its lipid lowering effect in two ways.
	Read more about Pravastatin
2	Fenofibrate UNII U202363UOS - FENOFIBRATE
	Fenofibrate is a fibric acid derivative whose lipid modifying effects reported in humans are mediated via activation of Peroxisome Proliferator Activated Receptor type α (PPARα). Through activation of PPARα, fenofibrate increases lipolysis and elimination of atherogenic triglyceride rich particles from plasma by activating lipoprotein lipase and reducing production of Apoprotein C-III.
	Read more about Fenofibrate

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
PRAVAFENIX Hard capsule	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C10BA03	Pravastatin and fenofibrate	C Cardiovascular system → C10 Lipid modifying agents → C10B Lipid modifying agents, combinations → C10BA Combinations of various lipid modifying agents
Discover more medicines within C10BA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1527061, 1527072, 1527083, 1598272
ES	Centro de información online de medicamentos de la AEMPS	11679004, 11679004IP
FR	Base de données publique des médicaments	60835453
IT	Agenzia del Farmaco	042556011, 042556023, 042556035, 042556047, 042556050, 042556062, 042556074
LT	Valstybinė vaistų kontrolės tarnyba	1059892, 1059893, 1059894, 1059895, 1059896, 1059897, 1067696
NL	Z-Index G-Standaard, PRK	101508
PL	Rejestru Produktów Leczniczych	100313227